Close Menu
    KSA NewslineKSA Newsline
    • Automotive

      Jaguar Type 01 electric GT debuts with 1,030 PS

      October 7, 2026

      Porsche to cut 5000 more jobs under restructuring plan

      July 28, 2026

      Japan new car sales rise 1.8% in first half of 2026

      July 2, 2026

      Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

      May 18, 2026

      Mercedes-Benz unveils electric C-Class in Seoul

      April 21, 2026
    • Business

      Morocco secures €434.4 million AfDB loan for reforms

      November 14, 2026

      ATI secures Manila South Harbour concession to 2063

      November 13, 2026

      Southeast Asia needs $7.1 trillion for infrastructure by 2040

      November 12, 2026

      Ghana Minority demands funding plan for $10bn New Economy

      November 11, 2026

      Samsung cash pile tops 200 trillion won, a first in Korea

      November 9, 2026
    • Entertainment

      Sony confirms God of War trilogy remake and PS5 prequel

      February 13, 2026

      Apple Arcade adds Jeopardy and NFL games in September update

      August 19, 2025

      Moscow hosts historic 47th international festival

      April 19, 2025

      Legal action against ‘Ketamine Queen,’ doctors in Perry overdose

      August 17, 2024

      Web3 leader Immutable rolls out $50M gaming rewards initiative

      April 27, 2024
    • Health

      Ebola cases top 11,200 as Africa CDC warns of record outbreak

      November 16, 2026

      Yellow fever kills 18 across nine African nations, WHO says

      November 7, 2026

      Dengue kills 173 in October as Bangladesh toll climbs to 418

      November 2, 2026

      Ebola deaths in DR Congo reach 5,340, fatality rate at 51.6%

      November 2, 2026

      Ebola death toll in DR Congo nears 4,900 as cases pass 10,000

      October 28, 2026
    • Lifestyle

      JP Morgan funds Fresha with $31 million for AI and robotics growth

      August 23, 2024

      Adidas, Highsnobiety debut limited-edition sneakers

      January 6, 2024

      Unraveling Starbucks’ phenomenon as a worldwide coffee powerhouse

      September 1, 2023

      How Nike’s Kobe 8 Protro Halo Marks an Emotional Milestone

      August 29, 2023

      From labels to legacy – understanding fashion’s hierarchy

      August 21, 2023
    • Luxury

      Global luxury market contracts for first time since Great Recession

      November 18, 2024

      Uncover the allure of Rolex Deepsea – luxury awaits.

      April 10, 2024

      Beyond timekeeping to the prestige of the Rolex Day-Date

      March 2, 2024

      Rare uncut emerald dazzles at Sharjah show

      February 1, 2024

      Porsche and Frauscher launch the electric 850 Fantom Air

      October 17, 2023
    • News

      Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

      November 17, 2026

      Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

      November 16, 2026

      Sheikh Mohamed receives Arab League chief Nabil Fahmy

      November 14, 2026

      Three nations launch carbon crediting initiative at COP31

      November 13, 2026

      Nigeria and EU seal readmission deal after decade of talks

      November 12, 2026
    • Sports

      Dakar 2026 Youth Olympic Games open Saturday in Senegal

      October 30, 2026

      Ballon d’Or 2026 nominees confirmed for London ceremony

      September 9, 2026

      Lionel Messi retires from Argentina after 21-year record run

      September 1, 2026

      Portugal fall to Spain as Ronaldo legacy closes

      July 7, 2026

      Brazil exits World Cup after Norway Round of 16 victory

      July 6, 2026
    • Technology

      MEAPMP Launches: Revamped Independent Ad-Tech & Premium Media Buying Across MEA

      November 3, 2026

      Sam Altman calls UAE most forward-looking country on AI

      November 3, 2026

      Apple iPhone Duo sets a new benchmark for foldable design

      November 2, 2026

      Apple brings Touch and PROLED XDR display to MacBook Pro

      October 29, 2026

      Integrated Identity Enters Global Top 0.1% with Rare 100/100 Google PageSpeed

      October 29, 2026
    • Travel

      Over 9 million visitors lift Tunisia tourism income 3.4%

      November 17, 2026

      Türkiye aims to rank sixth in global tourism revenue

      October 21, 2026

      Air Arabia launches Sharjah flights to Amman City Airport

      October 9, 2026

      Air Arabia resumes daily Ras Al Khaimah Kozhikode service

      October 7, 2026

      flydubai showcases growing Syria network with daily flights

      September 29, 2026
    KSA NewslineKSA Newsline
    Home » Pfizer adjusts earnings outlook despite pricing pressures
    Business

    Pfizer adjusts earnings outlook despite pricing pressures

    August 6, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Pfizer has raised its full-year adjusted earnings forecast for 2025, driven by cost-cutting measures and robust second-quarter performance that exceeded Wall Street expectations. The pharmaceutical giant now anticipates adjusted earnings per share between $2.90 and $3.10, up from its prior projection of $2.80 to $3.00. Pfizer maintained its revenue outlook for the year, which remains in the range of $61 billion to $64 billion.

    Global supply chains in focus as drugmakers adjust to tariff impacts. Credit – Pfizer.

    The improved forecast comes as Pfizer posted second-quarter earnings that beat analyst estimates. Adjusted earnings per share reached 78 cents, surpassing the expected 58 cents, while revenue rose to $14.65 billion, exceeding the anticipated $13.56 billion. This marks a 10% year-over-year increase in revenue, signaling a strong rebound for the company following a period of declining sales from its COVID-19 products.

    Pfizer attributed the revenue growth to stronger-than-expected sales across multiple products. Its COVID-19 vaccine, Comirnaty, generated $381 million in the second quarter, nearly doubling from the same period a year ago due to increased market share and international deliveries. Additionally, Pfizer’s antiviral treatment Paxlovid brought in $427 million, up 70% year-over-year, benefiting from a higher U.S. net price.

    Pfizer’s cost-cutting strategy strengthens 2025 earnings outlook

    Other key contributors included Vyndaqel for cardiomyopathy, the bladder cancer drug Padcev, and the blood thinner Eliquis, which Pfizer co-markets with Bristol Myers Squibb. However, these gains were partially offset by weaker sales of the breast cancer drug Ibrance, affected by pricing pressures from Medicare reforms and international generic competition.

    The company’s revised outlook accounts for a one-time charge of $1.35 billion related to a licensing agreement with Chinese  drugmaker 3SBio to develop and commercialize a cancer treatment outside China. Without this charge, Pfizer CFO David Denton noted the company’s profit guidance would have increased by an additional 30 cents per share.

    Pfizer’s financial performance arrives amid mounting political scrutiny over drug pricing. The company, along with other pharmaceutical firms, faces calls from President Donald Trump to lower U.S. drug prices. Trump’s administration has imposed tariffs on pharmaceutical imports from China, Canada, and Mexico, while proposing further measures such as the “most favored nation” policy to align U.S. drug prices with lower international rates.

    Analysts cautious despite Pfizer’s strong earnings streak and valuation

    Pfizer confirmed receiving a letter from the White House requesting concrete steps to reduce drug prices by September 29, with CEO Albert Bourla indicating that discussions with the administration have been “extremely productive.” Despite these regulatory challenges, Pfizer has expanded its cost-cutting initiatives. In April, the company announced an acceleration of its efficiency programs, targeting $7.7 billion in savings by the end of 2027.

    These initiatives are aimed at offsetting revenue declines from pandemic-era products and stabilizing the company’s financial trajectory. Pfizer’s shares rose over 4% following the earnings release, reflecting investor confidence in the company’s ability to navigate pricing pressures while delivering stronger-than-expected financial results. However, analysts continue to express caution regarding long-term growth, citing patent expirations and ongoing pricing challenges as key risks for the company. – By Content Syndication Services.

    Related Posts

    Morocco secures €434.4 million AfDB loan for reforms

    November 14, 2026

    ATI secures Manila South Harbour concession to 2063

    November 13, 2026

    Southeast Asia needs $7.1 trillion for infrastructure by 2040

    November 12, 2026

    Ghana Minority demands funding plan for $10bn New Economy

    November 11, 2026

    Samsung cash pile tops 200 trillion won, a first in Korea

    November 9, 2026

    FAO food price index falls 1.2% in October on cheaper cereals

    November 7, 2026
    Latest News

    Over 9 million visitors lift Tunisia tourism income 3.4%

    November 17, 2026

    – More than nine million tourists visited Tunisia by the end of October, lifting tourism revenues 3.4% year on year to more than $2 billion. Receipts totalled 7.152 billion dinars, equal to about $2.384 billion, Tourism Minister Sofiane Tekaya said.

    Sheikh Mohamed receives Venezuela’s Delcy Rodríguez in Abu Dhabi

    November 17, 2026

    Ebola cases top 11,200 as Africa CDC warns of record outbreak

    November 16, 2026

    Sheikh Mohamed and Ramos-Horta talk trade, energy and ASEAN

    November 16, 2026

    Sheikh Mohamed receives Arab League chief Nabil Fahmy

    November 14, 2026

    Morocco secures €434.4 million AfDB loan for reforms

    November 14, 2026

    Three nations launch carbon crediting initiative at COP31

    November 13, 2026

    ATI secures Manila South Harbour concession to 2063

    November 13, 2026
    © 2026 KSA Newsline | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.